These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6812524)

  • 1. Enterococci. Biologic and epidemiologic characteristics and in vitro susceptibility.
    Kaye D
    Arch Intern Med; 1982 Oct; 142(11):2006-9. PubMed ID: 6812524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of enterococci. I. Inhibitory and bactericidal activity of several chemoantibiotics against Streptococcus faecalis and Streptococcus faecium.
    Fabbri A; Manno G; Tacchella A; Belli ML; Palmero C
    Chemioterapia; 1986 Oct; 5(5):302-8. PubMed ID: 3098440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of azlocillin and other beta-lactam antibiotics against enterococci.
    Grimm H
    J Antimicrob Chemother; 1983 May; 11 Suppl B():43-9. PubMed ID: 6413483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of enterococci. II. Inhibitory and bactericidal activity of drugs in combination against Streptococcus faecalis and Streptococcus faecium.
    Fabbri A; Manno G; Tacchella A; Belli ML; Palmero C
    Chemioterapia; 1986 Oct; 5(5):309-12. PubMed ID: 3098441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enterococcal endocarditis.
    Wilkowske CJ
    Mayo Clin Proc; 1982 Feb; 57(2):101-5. PubMed ID: 6798333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The life and times of the Enterococcus.
    Murray BE
    Clin Microbiol Rev; 1990 Jan; 3(1):46-65. PubMed ID: 2404568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of Enterococcus faecalis to twelve antibiotics, time-kill assays, and high-level aminoglycoside resistance in a university hospital in Argentina.
    Predari SC; Gutiérrez MA; Ribas C; Molinari GS; Santoianni JE
    Rev Argent Microbiol; 1991; 23(2):67-78. PubMed ID: 1815269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of Streptococcus faecalis isolates with high-level resistance to multiple aminocyclitol aminoglycosides.
    Ikeda DP; Barry AL; Andersen SG
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3):171-7. PubMed ID: 6430629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of amoxycillin against enterococci and synergism with aminoglycoside antibiotics.
    Russell EJ; Sutherland R
    J Med Microbiol; 1975 Feb; 8(1):1-10. PubMed ID: 1039329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillin-tobramycin synergism against enterococci: a comparison with penicillin and gentamicin.
    Moellering RC; Wennersten C; Weinstein AJ
    Antimicrob Agents Chemother; 1973 Apr; 3(4):526-9. PubMed ID: 4208292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro evaluation of cefpirome (HR 810), teicoplanin and four other antimicrobials against enterococci.
    Chandrasekar PH; Price S; Levine DP
    J Antimicrob Chemother; 1985 Aug; 16(2):179-82. PubMed ID: 2933380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
    J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.
    Eliopoulos GM; Moellering RC
    Antimicrob Agents Chemother; 1981 May; 19(5):789-93. PubMed ID: 6794445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis and treatment of enterococcal infections.
    Gross MH; Barriere SL
    Clin Pharm; 1984; 3(2):161-6. PubMed ID: 6373101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of enterococci and epidemiology of enterococcal infection in the 1980s.
    George RC; Uttley AH
    Epidemiol Infect; 1989 Dec; 103(3):403-13. PubMed ID: 2514108
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endocarditis caused by group D streptococci. Comparison of the antibiotic sensitivity of S. bovis and enterococci].
    Bastin R; Dournon E; Huchon A; Bricaire F; Bure A; Frottier J; Vildé JL
    Rev Med Interne; 1981 Oct; 2(3):257-62. PubMed ID: 6794122
    [No Abstract]   [Full Text] [Related]  

  • 20. In-vitro and in-vivo activity of cefpirome (HR 810) against methicillin-susceptible and -resistant Staphylococcus aureus and Streptococcus faecalis.
    Eng RH; Cherubin CE; Smith SM; Buccini F; Harris R
    J Antimicrob Chemother; 1989 Mar; 23(3):373-81. PubMed ID: 2499565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.